Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0098 | 0.1595 | 1 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.017 | 0.3119 | 0.8065 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0045 | 0.0469 | 0.1912 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0077 | 0.1149 | 0.1149 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0077 | 0.1149 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0202 | 0.381 | 1 |
Brugia malayi | RNA binding protein | 0.0202 | 0.381 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0038 | 0.0308 | 0.0205 |
Loa Loa (eye worm) | beta-lactamase | 0.0077 | 0.1149 | 0.2556 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1149 | 0.2556 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0077 | 0.1149 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0202 | 0.381 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0077 | 0.1149 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0045 | 0.0469 | 0.0459 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.1912 |
Loa Loa (eye worm) | RNA binding protein | 0.0202 | 0.381 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0202 | 0.381 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0077 | 0.1149 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0077 | 0.1149 | 0.2401 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0077 | 0.1149 | 0.1149 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1149 | 0.2556 |
Mycobacterium leprae | Probable lipase LipE | 0.0077 | 0.1149 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0077 | 0.1149 | 0.1149 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0038 | 0.0308 | 0.0205 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.0235 | 0.2043 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0077 | 0.1149 | 0.2401 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.0235 | 0.2043 |
Brugia malayi | beta-lactamase | 0.0077 | 0.1149 | 0.2556 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1149 | 0.2556 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0077 | 0.1149 | 1 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0077 | 0.1149 | 0.1149 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0202 | 0.381 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.017 | 0.3119 | 0.8025 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.1912 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0077 | 0.1149 | 0.2556 |
Brugia malayi | beta-lactamase family protein | 0.0077 | 0.1149 | 0.2556 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0038 | 0.0308 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0077 | 0.1149 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1149 | 0.2556 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0077 | 0.1149 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1149 | 0.2556 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0077 | 0.1149 | 0.2556 |
Schistosoma mansoni | tar DNA-binding protein | 0.0202 | 0.381 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0077 | 0.1149 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0077 | 0.1149 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.017 | 0.3119 | 0.8025 |
Trichomonas vaginalis | esterase, putative | 0.0077 | 0.1149 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0202 | 0.381 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.017 | 0.3119 | 0.8065 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.017 | 0.3119 | 0.8025 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0038 | 0.0308 | 0.5 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0077 | 0.1149 | 0.2401 |
Mycobacterium ulcerans | beta-lactamase | 0.0077 | 0.1149 | 1 |
Brugia malayi | TAR-binding protein | 0.0202 | 0.381 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0077 | 0.1149 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0077 | 0.1149 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0077 | 0.1149 | 0.1149 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.1912 |
Schistosoma mansoni | tar DNA-binding protein | 0.0202 | 0.381 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0077 | 0.1149 | 0.1149 |
Plasmodium vivax | hypothetical protein, conserved | 0.0077 | 0.1149 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0202 | 0.381 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0077 | 0.1149 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0077 | 0.1149 | 0.1149 |
Trypanosoma brucei | glucosidase, putative | 0.0038 | 0.0308 | 0.2679 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Trypanosoma brucei | unspecified product | 0.0038 | 0.0314 | 0.2733 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Schistosoma mansoni | alpha-glucosidase | 0.0146 | 0.2615 | 0.6589 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0045 | 0.0469 | 0.1912 |
Mycobacterium ulcerans | hypothetical protein | 0.0077 | 0.1149 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0038 | 0.0314 | 0.2733 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.1912 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 0.0469 | 0.4079 |
Mycobacterium tuberculosis | Conserved protein | 0.0077 | 0.1149 | 0.1149 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Echinococcus multilocularis | dna polymerase kappa | 0.0045 | 0.0469 | 0.0459 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0077 | 0.1149 | 0.1149 |
Brugia malayi | beta-lactamase family protein | 0.0077 | 0.1149 | 0.2556 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 0.0469 | 0.4079 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1149 | 0.2556 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0469 | 0.4079 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0038 | 0.0308 | 0.2679 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0077 | 0.1149 | 0.2401 |
Leishmania major | hypothetical protein, conserved | 0.0077 | 0.1149 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0202 | 0.381 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0077 | 0.1149 | 0.1149 |
Schistosoma mansoni | alpha-glucosidase | 0.0146 | 0.2615 | 0.6589 |
Schistosoma mansoni | tar DNA-binding protein | 0.0202 | 0.381 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0077 | 0.1149 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = -1 % | DNDI: Inhibition of Human African Trypanosomiasis, SBRI 427, in vitro at 2 ug.mL-1 | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.